Screening compound: DHHBSBVBORZIOM-VWLOTQADSA-N

Screening compound: DHHBSBVBORZIOM-VWLOTQADSA-N
Screening compound: DHHBSBVBORZIOM-VWLOTQADSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
DHHBSBVBORZIOM-VWLOTQADSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L610-0056

Molecular Formula

C28H31N3O3 (C28 H31 N3 O3)

Compound Name

N~1~-[2-(1-cyclohexenyl)ethyl]-4-{[5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]methyl}benzamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-4-({28-dioxo-39-diazatricyclo[8.4.0.0^{37}]tetradeca-1(14)1012-trien-9-yl}methyl)benzamide

SMILES

O=C(c1ccc(CN(c(cccc2)c2C(N2C3CCC2)=O)C3=O)cc1)NCCC1=CCCCC1

InChI

InChI=1S/C28H31N3O3/c32-26(29-17-16-20-7-2-1-3-8-20)22-14-12-21(13-15-22)19-31-24-10-5-4-9-23(24)27(33)30-18-6-11-25(30)28(31)34/h4-5,7,9-10,12-15,25H,1-3,6,8,11,16-19H2,(H,29,32)/t25-/m0/s1

InChI Key

DHHBSBVBORZIOM-VWLOTQADSA-N

MDL Number (MFCD)

MFCD27465799

DHHBSBVBORZIOM-VWLOTQADSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Anti-HIV1 Library (19540 compounds)

Epigenetics Focused Set (26518 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
Targets:
  • Kinases
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with DHHBSBVBORZIOM-VWLOTQADSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound DHHBSBVBORZIOM-VWLOTQADSA-N?
Check Price and Availability of DHHBSBVBORZIOM-VWLOTQADSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of DHHBSBVBORZIOM-VWLOTQADSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for DHHBSBVBORZIOM-VWLOTQADSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for DHHBSBVBORZIOM-VWLOTQADSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of DHHBSBVBORZIOM-VWLOTQADSA-N available by request